Lassa Virus Infection in Experimentally Infected Marmosets: Liver Pathology and Immunophenotypic Alterations in Target Tissues

ABSTRACT Lassa virus causes thousands of deaths annually in western Africa and is considered a potential biological weapon. In an attempt to develop a small nonhuman primate model of Lassa fever, common marmosets were subcutaneously inoculated with Lassa virus strain Josiah. This inoculation resulted in a systemic disease with clinical and morphological features mirroring those in fatal human Lassa infection: fever, weight loss, high viremia and viral RNA load in tissues, elevated liver enzymes, and severe morbidity between days 15 and 20. The most prominent histopathology findings included multifocal hepatic necrosis with mild inflammation and hepatocyte proliferation, lymphoid depletion, and interstitial nephritis. Cellular aggregates in regions of hepatocellular necrosis were largely composed of HAM56-positive macrophages, devoid of CD3-positive and CD20-positive cells, and characterized by marked reductions in the intensity of HLA-DP, DQ, DR staining. A marked reduction in the major histocompatibility complex class II expression was also observed in the lymph nodes. Immunophenotypic alterations in spleen included reductions in overall numbers of CD20-positive and CD3-positive cells and the disruption of lymphoid follicular architecture. These findings identify the common marmoset as an appropriate model of human Lassa fever and present the first experimental evidence that replication of Lassa virus in tissues is associated with alterations that would be expected to impair adaptive immunity.

[1]  S. White,et al.  RNAi-mediated chromatin silencing in fission yeast. , 2008, Current topics in microbiology and immunology.

[2]  I. Lukashevich,et al.  A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. , 2007, Vaccine.

[3]  A. Pithawa,et al.  Sleisenger and Fordtran's Gastrointestinal and Liver Disease: pathophysiology, diagnosis, management , 2007 .

[4]  M. Wolfe,et al.  Historical Lassa Fever Reports and 30-year Clinical Update , 2006, Emerging infectious diseases.

[5]  M. Georges-Courbot,et al.  Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages. , 2006, Microbes and infection.

[6]  V. Deubel,et al.  A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. , 2006, Virology.

[7]  I. Lukashevich,et al.  A Live Attenuated Vaccine for Lassa Fever Made by Reassortment of Lassa and Mopeia Viruses , 2005, Journal of Virology.

[8]  T. Greenough,et al.  Pneumonitis and Multi-Organ System Disease in Common Marmosets (Callithrix jacchus) Infected with the Severe Acute Respiratory Syndrome-Associated Coronavirus , 2005, The American Journal of Pathology.

[9]  S. Davern,et al.  Systemic AA Amyloidosis in the Common Marmoset , 2005, Veterinary pathology.

[10]  R. Carrion,et al.  Demand for Nonhuman Primate Resources in the Age of Biodefense , 2005, ILAR journal.

[11]  K. Mansfield,et al.  GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology. , 2004, The Journal of general virology.

[12]  I. Lukashevich,et al.  LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration , 2004, Archives of Virology.

[13]  J. McCormick,et al.  Lassa fever vaccine , 2004, Expert review of vaccines.

[14]  M. Georges-Courbot,et al.  Lassa Virus Infection of Human Dendritic Cells and Macrophages Is Productive but Fails to Activate Cells1 , 2004, The Journal of Immunology.

[15]  K. Mansfield,et al.  Marmoset models commonly used in biomedical research. , 2003, Comparative medicine.

[16]  B. Pulendran,et al.  Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses1 , 2003, The Journal of Immunology.

[17]  I. Lukashevich,et al.  Arenavirus-Mediated Liver Pathology: Acute Lymphocytic Choriomeningitis Virus Infection of Rhesus Macaques Is Characterized by High-Level Interleukin-6 Expression and Hepatocyte Proliferation , 2003, Journal of Virology.

[18]  B. Pulendran,et al.  Impairment of dendritic cells and adaptive immunity by Ebola and lassa viruses , 2003 .

[19]  Mark Feldman,et al.  Sleisenger and Fordtran's gastrointestinal and liver disease , 2012 .

[20]  Philip K. Russell,et al.  Hemorrhagic fever viruses as biological weapons: medical and public health management. , 2002, JAMA.

[21]  M. Oldstone Biology and pathogenesis of lymphocytic choriomeningitis virus infection. , 2002, Current topics in microbiology and immunology.

[22]  P. Jahrling,et al.  Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses , 2001, Journal of Virology.

[23]  P. Rollin,et al.  Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. , 2001, The Journal of infectious diseases.

[24]  S. Günther,et al.  First outbreak of callitrichid hepatitis in Germany: genetic characterization of the causative lymphocytic choriomeningitis virus strains. , 2001, Virology.

[25]  L. Hutwagner,et al.  Effective Vaccine for Lassa Fever , 2000, Journal of Virology.

[26]  I. Lukashevich,et al.  Lassa and mopeia virus replication in human monocytes/macrophages and in endothelial cells: Different effects on IL‐8 and TNF‐α gene expression , 1999, Journal of medical virology.

[27]  Douglas R. Morgan,et al.  Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management , 1998 .

[28]  K. Holmes,et al.  Pathology and immunohistochemistry of callitrichid hepatitis, an emerging disease of captive New World primates caused by lymphocytic choriomeningitis virus. , 1995, The American journal of pathology.

[29]  C. Stephensen,et al.  cDNA sequence analysis confirms that the etiologic agent of callitrichid hepatitis is lymphocytic choriomeningitis virus , 1995, Journal of virology.

[30]  J. Maniloff,et al.  Virus taxonomy : eighth report of the International Committee on Taxonomy of Viruses , 2005 .

[31]  D. Brown,et al.  Early diagnosis of Lassa fever by reverse transcription-PCR , 1994, Journal of clinical microbiology.

[32]  R. Ward,et al.  A common-source outbreak of callitrichid hepatitis in captive tamarins and marmosets. , 1993, The Journal of infectious diseases.

[33]  J. McCormick,et al.  Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection. , 1988, Virus research.

[34]  G. Lloyd,et al.  VACCINIA RECOMBINANT EXPRESSING LASSA-VIRUS INTERNAL NUCLEOCAPSID PROTEIN PROTECTS GUINEAPIGS AGAINST LASSA FEVER , 1987, The Lancet.

[35]  B. Tandon,et al.  1 Viral diseases involving the liver , 1987 .

[36]  E. S. Smith,et al.  A prospective study of the epidemiology and ecology of Lassa fever. , 1987, The Journal of infectious diseases.

[37]  R. Laguens,et al.  Protection of junín virus‐infected marmosets by passive administration of immune serum: Association with late neurologic signs , 1987, Journal of medical virology.

[38]  P. Jahrling,et al.  Experimental studies of arenaviral hemorrhagic fevers. , 1987, Current topics in microbiology and immunology.

[39]  B. Tandon,et al.  Viral diseases involving the liver. , 1987, Bailliere's clinical gastroenterology.

[40]  J. McCormick,et al.  Therapeutic Effect of the Antiviral Agent Ribavirin in Junin Virus Infection of Primates , 1986, Journal of medical virology.

[41]  J. McCormick,et al.  Lassa virus hepatitis: a study of fatal Lassa fever in humans. , 1986, The American journal of tropical medicine and hygiene.

[42]  J. McCormick,et al.  Lassa fever. Effective therapy with ribavirin. , 1986, The New England journal of medicine.

[43]  Lukashevich Is Lassa virus lethality for inbred mice. , 1985 .

[44]  I. Lukashevich Lassa virus lethality for inbred mice. , 1985, Annales de la Societe belge de medecine tropicale.

[45]  R. Laguens,et al.  Junin virus infection of Callithrix jacchus: pathologic features. , 1983, The American journal of tropical medicine and hygiene.

[46]  J. McCormick,et al.  Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus. , 1982, The Journal of infectious diseases.

[47]  P. Jahrling,et al.  Pathology of Lassa virus infection in the rhesus monkey. , 1982, The American journal of tropical medicine and hygiene.

[48]  P. Jahrling,et al.  Pathogenesis of Lassa virus infection in guinea pigs , 1982, Infection and immunity.

[49]  J. McCormick,et al.  Pathologic and virologic study of fatal Lassa fever in man. , 1982, The American journal of pathology.

[50]  E. Damonte,et al.  Cross-protection in nonhuman primates against Argentine hemorrhagic fever , 1982, Infection and immunity.

[51]  A. Anusz [Lassa fever]. , 1981, Pielegniarka i polozna.

[52]  P. Jahrling,et al.  Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. , 1980, The Journal of infectious diseases.

[53]  T. Monath,et al.  Lassa virus hepatitis. Observations on a fatal case from the 1972 Sierra Leone epidemic. , 1975, Archives of pathology.

[54]  F. Murphy,et al.  Comparative pathology of Lassa virus infection in monkeys, guinea-pigs, and Mastomys natalensis. , 1975, Bulletin of the World Health Organization.